Every time I present on male infertility, it's clear that this topic needs more attention. Over the last week, I had the privilege of presenting different treatment options for male infertility and exploring ways we can improve ART outcomes—but also improve awareness and understanding. The novel APHRODITE criteria featured in the agenda was an important step towards balancing the attention already given to female infertility. This approach helps us achieve the best outcomes for the couples we treat, even when ART is utilized. It was an honor to share insights with healthcare professionals from the UK in Liverpool and the Asia Pacific in Kuala Lumpur. The enthusiasm, thoughtful questions, and engaging discussions demonstrated our shared commitment to advancing care in this critical area. Thank you, Merck UK team and Bitoul Zidan, for having me in this year's SMART Masterclass. Thank you, Merck Global, Akram Kharbat, and the supporting agencies Circular Communications and WeLoveDigi, for having me in the Fertility AcadeMe in Malaysia and organizing such top-tier educational events. And a big thanks to everyone who participated and contributed to this important conversation—your engagement is the driving force behind progress. Together, we are making a difference in the lives of patients. Let's keep the momentum going! #maleinfertility #andrology #reproductivemedicine #APHRODITEcriteria
Thanks Sandro Esteves , Male infertility is still a subject to be explored , particularly here in africa where such matter has been for a long time a real taboo
Dear Sandro, thank you for your kind words! It’s always a pleasure to collaborate with you.
Thanks for sharing, Professor!
Very well said!
Scientific Director Global Medical Communication and Education
3moThe pleasure is ours Dr. Sandro. Thank you for your significant contribution and your insightful talk during the APAC acadeMe. Sandro Esteves Denitsa Bacheva Jessica Buckey (Thilaganathan)